<--- Back to Details
First PageDocument Content
Heparins / Deep vein thrombosis / Rivaroxaban / Thrombosis / Patient safety / Venous thrombosis / Alberta Health Services / Sunnybrook Health Sciences Centre / Pulmonary embolism / Medicine / Health / Hematology
Date: 2012-07-31 11:20:23
Heparins
Deep vein thrombosis
Rivaroxaban
Thrombosis
Patient safety
Venous thrombosis
Alberta Health Services
Sunnybrook Health Sciences Centre
Pulmonary embolism
Medicine
Health
Hematology

Microsoft Word - VTE EN may27.docx

Add to Reading List

Source URL: www.saferhealthcarenow.ca

Download Document from Source Website

File Size: 3,25 MB

Share Document on Facebook

Similar Documents

3273 Pan-Selectin Antagonist, GMI-1070 Decreases Venous Thrombosis in a Mouse Model Program: Hemostasis and Thrombosis Session: Vascular Wall Biology, Endothelial Progenitor Cells and Platelet Adhesion Tuesday, December

DocID: 1vs8t - View Document

Catheter-Directed Thrombolysis with Direct Intra-Catheter Administration of Argatroban and Alteplase for Extensive Deep Vein Thrombosis in a Patient with Heparin-Induced Thrombocytopenia

DocID: 1vmHH - View Document

TECHNOLOGY OFFER Novel platelet biomarkers for detection of thrombosis risk We hereby present novel biomarkers for the detection of platelet reactivity. These new biomarkers allow the risk estimation for people having a

DocID: 1v9bO - View Document

Cerebral Venous Sinus Thrombosis: Incidence and Hyperhomocysteinemia as a Risk Factor in Japanese Patients

DocID: 1uso0 - View Document

Antithrombotic Therapy in Neonates and Children: Antithrombotic Therapy and Prevention of Thrombosis COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER

DocID: 1umyU - View Document